Related Experiment Video
Updated: Feb 11, 2026

Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding
Published on: February 26, 2015
Layered skin-like hydrogel for long-acting drug release to achieve staged chronic wound healing
1Department of Nursing, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China; Nursing College, Hangzhou Normal University, Hangzhou, China.
Abstract:
Chronic wounds severely threaten patient health and exacerbate the medical burden, with prolonged healing requiring long-term drug intervention. Current dressings cannot maintain effective therapeutic concentrations, and the complex healing process urgently needs long-acting treatment strategies. This study innovatively develops a biomimetic skin bilayer hydrogel: the upper layer, a GelMA-carboxylated cellulose nanocrystal (CNC) composite crosslinked by light, mimics the epidermal barrier to prevent secondary injury; the lower layer, based on GelMA and loaded with heparan sulfate (HS) in porous poly(dopamine) nanoparticles (PDA@NPs), simulates the angiogenic properties of the dermis. The porous structure of PDA@NPs enables higher HS loading, reinforces and integrates the interface, and, through spontaneous drug diffusion, forms a bottom-up concentration gradient drug delivery system for sustained release. This system accelerates wound repair through synergistic anti-inflammatory, vascular reconstruction, and physical barrier mechanisms, providing a safe and efficient new strategy for chronic wound management.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers
Drugs Affecting Neurotransmitter Release or Uptake
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
In Vitro Drug Release Testing: Overview, Development and Validation
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

